Overview of the Situation#
FibroBiologics Inc (NASDAQ:FBLG) experienced a significant drop in its stock price, falling 22.2% in after-hours trading on Wednesday. This decline followed the company's announcement of a 1-for-20 reverse stock split, a move intended to meet Nasdaq listing requirements.
What is a Reverse Stock Split?#
A reverse stock split is a process where a company reduces the number of its outstanding shares while increasing the share price proportionally. In this case, every 20 shares of FibroBiologics will combine into one share, effectively reducing the total number of shares from approximately 70 million to about 3.5 million. This adjustment will take effect at 12:01 a.m. Eastern Time on March 30, 2026.
Purpose of the Reverse Split#
The Board of Directors of FibroBiologics approved this reverse split to regain compliance with Nasdaq's minimum bid price requirement. This requirement is in place to ensure that stocks maintain a certain price level to remain listed on the exchange. The company hopes that this move will also attract more investor interest.
Implications for Shareholders#
Shareholders will not see any change in their overall ownership percentage in the company due to the reverse split, except for minor adjustments related to fractional shares. Additionally, the number of authorized shares will remain unchanged, and the reverse split will adjust the shares available under the company's equity incentive plans and the exercise prices of stock options and warrants. VStock Transfer, LLC will serve as the exchange agent for this process, and a new CUSIP number will be assigned to the company's common stock after the split.